Starting in 2015, the American Society of Transplantation Psychosocial Community of Practice, with representatives of the Transplant Pharmacy Community of Practice, convened a taskforce to develop a white paper that focused on clinically practical, evidenced-based interventions that transplant centers could implement to increase adherence to medication and behavioral recommendations in adult solid organ transplant recipients. The group focused on what centers could do in their daily routines to implement best practices to increase adherence in adult transplant recipients. We developed a list of strategies using available resources, clinically feasible methods of screening and tracking adherence, and activities that ultimately empower patients to improve their own self-management. We limited the target population to adults because they predominate the research, and because adherence issues differ in pediatric patients, given the necessary involvement of parents/guardians. We also examined broader multilevel areas for intervention including provider and transplant program practices. Ultimately, the task force aims to foster greater recognition, discussion, and solutions required for implementing practical interventions targeted at improving adherence.
| INTRODUC TI ON
Adherence, dynamic and multifaceted, is "the extent to which a person's behavior -taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider." 1 The World Health Organization outlines five overarching dimensions or factors that impact adherence, including the following: health system/healthcare team, social/ economic, condition-related, therapy-related, and patient-related.
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Despite challenges patients may face in these dimensions, it is recommended that individuals living with a solid organ transplant maintain adherence for successful clinical outcomes.
Meta-analytic findings show that, on average, 23 per 100 organ transplant patients per year are nonadherent with immunosuppressant medications, 2 and that nonadherence to the medical regimen increases with time post-transplant. 2 Patients may have occasional or intermittent lapses in adherence, variability in immunosuppression exposure, or differences in immunologic risk; thus, the clinical outcomes of nonadherence vary. 3 Nonadherence has been associated with acute rejection, post-transplant infections, decreased graft survival, increased medical costs, and overall mortality. 4 Given the potential for serious adverse outcomes, a multimodal approach to post-transplant adherence, including assessment for identifying nonadherence, education for patients and caregivers, and multilevel systematic evaluation and improvement strategies to assist with adherence should be incorporated into the care of all transplant patients. Based on survey data, however, only about half of US transplant centers have protocols to evaluate adherence. 5 When attempts are made to increase adherence, the most commonly used intervention is providing reading materials, which has not been found to be effective when used in isolation. 6 Currently, there are no guidelines outlining best practice interventions that can be used by transplant centers to increase adherence after and maintain patient adherence, we developed a list of strategies that includes existing resources and clinically feasible methods of screening and tracking adherence. We focused on adult organ recipients as this is the primary population studied, and because adherence issues and interventions in pediatric patients differ. We examined interventions based on patient, provider and transplant program practices because adherence is influenced by multiple factors. We did not include policy-level systemic solutions (ie, better coverage of medication costs through long-term Medicare immunosuppression coverage), as these interventions would not be within the direct control of the transplant center. Given the existence of other comprehensive reviews on adherence in transplant patients, 4 we focused on issues related to feasibility for clinical application, scalability, and dissemination. We identified the key findings from the literature and then came to consensus about best practices for adherence assessment and intervention.
| RIS K FAC TOR S FOR NONADHEREN CE
Research has identified numerous modifiable and nonmodifiable factors that play a role in the risk of nonadherence among solid organ transplant recipients, pre-and post-transplant (Table 1) . Risk factors are often inconsistently associated with nonadherence; 2, 4, 7 and the ability of specific risk factors to predict nonadherence varies by the adherence behavior that is being studied (eg, medication adherence vs other adherence behaviors). Therefore, we propose early identification (pretransplant) of potential risk factors and barriers to allow for targeted intervention and heightened monitoring.
When warranted, pretransplant psychosocial and adherence evaluation may allow pretransplant interventions to be performed to mitigate post-transplant nonadherence. Once risk factors and barriers to adherence are identified, interventions to promote adherence should be implemented throughout the transplant process.
| TOOL S TO A SS E SS NONADHEREN CE
Previous reviews have identified numerous ways to measure adherence. 8 Although multimodal adherence assessment is recommended, 8 and it may be synergistic to use 2-3 methods simultaneously, this approach may not be practical or even possible in routine clinical practice often due to cost, time, or staffing constraints.
The top priorities of adherence screening in a clinical setting are to detect nonadherence, implement interventions, then track progress over time. The objective for selecting an adherence measure should be to balance reliability and validity with practicability for administration. Table 2 details the strengths and weaknesses of common approaches, along with recommendations for their use.
Perhaps the most expedient and efficient means of screening for adherence at a low cost in a clinical setting is patient self-report through standardized survey instruments. Disadvantages to patient self-report include lower specificity, sensitivity, and precision about the extent of nonadherence, and the potential for reporting bias due to either poor recall or an interest in giving the healthcare provider the desired response. 10 However, a meta-analysis 2 showed that self-report assessments captured higher rates of nonadherence to immunosuppressants than other assessment methods. In addition, they may be superior to other measures of assessing nonadherence because they are less expensive and labor intensive, and more practical in clinical settings compared to other methods. Disadvantages of self-reports may be minimized if they are administered in a nonjudgmental way and conservative cutoffs are chosen to define nonadherence to reduce bias from underreporting nonadherence. 9 The strengths and weaknesses of other methods, including provider reports, medication refill reports, medication blood level metrics, electronic medication event monitoring devices, remote spirometry for lung transplantation, and other biological assays are detailed in Table 2 . Due to underestimation, we do not recommend the sole use of provider reports of nonadherence. 11 Although providers are encouraged to conduct standardized reviews of medical records to examine patients' adherence to laboratories and clinic visits, multimodal methods of nonadherence assessment are more sensitive. 11 Similarly, although there are some attractive properties of medication refill reports, electronic medication event monitoring devices, and assays of medication levels in patients'
blood, there are also potentially prohibitive disadvantages including availability of resources to obtain medication refill reports and access to electronic medications event monitoring devices.
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Despite these concerns, electronic monitoring devices can provide detailed data on medication-taking initiation, execution, and persistence, which are key components for identifying opportunities for interventions.
| B E S T PR AC TI CE S FOR INTERVENTI ON S
In Table 3 , we summarize interventions that have been tested and found efficacious, their key components, implementation benefits, challenges, and other considerations. Transplant centers with diverse needs, patient populations, and resources for adherence monitoring and interventions may need to tailor the implementation of these efforts in different ways, and it is likely that no "one-size-fitsall" approach is warranted to recommend to all transplant centers.
| Educational intervention
Education is the most frequently used method by transplant staff to encourage patient adherence. 6 Education is often necessary to ensure patients' understanding of their condition and treatment.
Transplant patients and their supports report the need for comprehensive education related to transplantation. 6 The duration and content of educational interventions range from brief and general (eg, • Longer time since transplant a Self-efficacy-an individual's belief that he or she has the ability to implement a behavior that will produce a desired outcome. b Self-care agency-an individual's cognitive and physical/behavioral ability to engage in self-care, this includes the ability to perform behaviors aimed at maintaining health and well-being. 
TA B L E 2 Comparison of approaches to measuring adherence for clinicians

| Cognitive/behavioral interventions
Interventions aimed at improving adherence through repeated visits with transplant team members and/or through implementing memory or monitoring strategies may be characterized as cognitive/ behavioral interventions. 4 Many of these interventions involve discussions regarding patients' motivation for adherence, involvement of social support, addressing barriers to adherence, and implementing strategies to enhance adherence, such as assistive tools (eg, alarm, a pill box) or receiving reminders from others.
4,13
Behavioral contracts have been used before and after transplant to increase adherence with medication and other behaviors. 14 In behavioral contracting, the patient and a provider identify a specific health behavior to address, then write an agreement (the contract) describing how the behavior will be modified to achieve the desired effect. 14 Contracting is designed to increase patients' sense of selfefficacy, or belief in their ability to accomplish a goal, which is cor- 
| Health information technology intervention strategies
Health information technology (HIT) applications are used increasingly often by both healthcare professionals and patients. HIT applications include traditional software run on desktop and laptop computers,
Internet-based strategies, personal electronic monitoring devices that track routine daily behaviors (eg, fitness devices), and smartphone apps. The ubiquity and widespread acceptance of apps by all types of users suggest that they may be prime strategies for transplant 
TA B L E 3 (Continued)
programs to harness and facilitate patient adherence. 21 Within organ transplantation, studies have begun to examine the efficacy of some HIT approaches. 21 This work is summarized below and leads to our suggestions in Table 3 regarding potential benefits and challenges for transplant programs to consider if they seek to use any of four HIT approaches to improve or maximize patients' medical adherence.
A notable example of a smartphone app that has undergone user- patients about when to seek assistance from the transplant team. In a randomized controlled trial, Pocket PATH users showed better selfmonitoring and adherence. 22 A critical element of effective apps is that they include multiple components; single-component apps, (eg, those providing only educational information) do not appear useful.
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Useful websites that discuss and compare available apps are https:// publichealthonline.gwu.edu/quantified-self-health-tracking-technology/ and www.medappfinder.com, and several reviews of commercially available apps for general health behavior and adherence to medication specifically have been published in recent years.
Reviews conclude that an increasing number of patients have access, are willing to use, and are highly satisfied with smartphone apps, but that interest in using an app decreases over time.
Websites for patient health promotion and medical regimen adherence have been found effective in various chronic disease populations. 23 Many transplant programs now host their own webpages, either within the websites of their home institutions or through other sources (eg, Facebook). Although often focused on educational information, programs could consider including other features found useful in chronic disease and transplant populations, including bulletin boards for (nonurgent) patient questions and comments, opportunities for patients to upload personal data to monitor trends over time, and interactive workshops. These features may benefit patients and be time-saving for programs, such as face-to-face education, obtaining more detailed information, skills-building activities, or tools to monitor self-care activities. However, resources would be needed to ensure that materials were updated regularly and that patients' posted comments or questions were appropriate and not about urgent issues.
Providing patients with prompts, alerts, or reminders to take medications or perform other activities also improves medical regimen adherence. 13 Studies of medication taking suggest that monitoring systems that include multiple components (eg, reminders emitted by medication dispensers combined with smartphone app reminders, tracking capabilities, and text messaging) are more likely to promote adherence 24 than are simple medication dispensers with alerts or alarms used in isolation. 25 However, the studies in transplant recipients have followed patients for relatively short periods of time (a year or less), 24, 25 and the long-term durability of any effects is unknown. and costly of the HIT interventions discussed and may be highly feasible for most transplant programs to implement and routinely use.
| CON CLUS I ON S AND RECOMMENDATIONS
Although we have emphasized the costs and limitations of measuring, monitoring, and intervening upon nonadherence, it is also use. If such activities are seen as the sole responsibility of only one team member, it is likely that both patients and the team as a whole will continue to see the activities as peripheral rather than central to patient care.
CO N FLI C T O F I NTE R E S T
None. 
O RCI D
Larissa
